About this trial
This is a prospective observation cohort investigation. Patients, that is participants, undergoing primary functional rhinoplasty will be evaluated in terms of measuring capillary blood lactic acid concentration in the nasal skin-soft tissue envelope immediately after the procedure and 7 days after the procedure.
The aim of our study is to test whether or not different rhinoplasty approaches and volume of the used autologous cartilage grafts impact the nasal skin-soft tissue metabolism.
Eligibility criteria
Qualifiers
Adult patients undergoing primary functional rhinoplasty who comply with the study
Adult patients undergoing primary functional rhinoplasty who have singed the informed consent, previously approved by the ethics commitee.
Disqualifiers
patients with previous surgical procedures to the nose
patients with greater previous injury or burns to the nasal skin
patients with autoimmune skin conditions
patients with significant cardiovascular diseases
Trial design
Treatments tested in this trial
- Not listed